We are live on
!
Find out more
B
Bpifrance Portfolio holdings
AUM
$1.65B
1-Year Est. Return
19.85%
This Fund
S&P 500
This Quarter
Est. Return
-4.61%
1 Year Est. Return
-19.85%
3 Year Est. Return
-49.36%
5 Year Est. Return
-48.43%
10 Year Est. Return
–
AUM
$2.58B
AUM Growth
-$93M
(-3.5%)
Cap. Flow
-$4.35M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veracyte
VCYT
|
+$3.03M |
| 2 |
CLLS
Cellectis
CLLS
|
+$1.21M |
| 3 |
RPTX
Repare Therapeutics
RPTX
|
+$113K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 89.24% |
| 2 | Materials | 6.43% |
| 3 | Communication Services | 2.84% |
| 4 | Healthcare | 0.65% |
| 5 | Technology | 0.46% |
Similar funds
CCM
BFPW
PP
ACM
NSIM
RIA
GACM
ELI
Bpifrance's Q3 2022 Portfolio in Review
As of Q3 2022, Bpifrance held 9 positions worth $2.58B, down 3.5% from $2.68B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bpifrance's Q3 2022 filing shows 3 closed positions. The largest sale was Veracyte, an estimated $3.03M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 89% of assets, up from 88% a quarter earlier, followed by Materials and Communication Services.
- Bpifrance fully exited Veracyte in Q3 2022, selling an estimated $3.03M.
- Bpifrance's ten largest holdings make up 100% of its $2.58B portfolio in Q3 2022.
- Bpifrance opened 0 new positions and closed 3 in Q3 2022.
- Bpifrance's portfolio value fell 3.5% quarter-over-quarter to $2.58B.
Based on Bpifrance's 13F filing for Q3 2022, filed 14 Nov 2022.